IFNG and neoplasm: In this study, we investigated the effect of alemtuzumab on the cell death of NK cells at a clinically relevant concentration, and characterized CD52− NK cells by examining cytotoxicity toward tumor cells and IFN-γ production in vitro by using purified NK cells, especially from the liver.